AlphaMoats
Health Care

UROGEN PHARMA LTD URGN

$40.63
Price at quarter end (Q3 2026)
Superinvestor owners
1
Rank #1465 by number of owners
% of all portfolios
0.00%
Rank #1450 by combined value
Net managers Q2 2026
+1
1 in · 0 out
Hold price
—
Weighted avg. reported price
Largest position
0.0%
of Polen Capital's portfolio

Live price

Compare with the quarter-end price of $40.63 reported in the 13F

Superinvestors holding URGN

Recent activity
Polen Capital · Polen Capital Management
0.0%
▲ Add+58.0%$1.9M